Por Renan Filho · 2026-10-10**Lead**
Since the devastating Hamas-led assault on October 7, 2023, the Israel Defense Forces have quietly transformed their approach to combat medicine, achieving a steep reduction in the proportion of wounded soldiers who die from their injuries. The improvements — driven by faster evacuation, aggressive hemorrhage control, and decentralized decision-making — have drawn intense scrutiny from the United States military, which is now working to integrate Israeli lessons into its own battlefield protocols.
**Context**
The October 7 attack, in which Hamas and allied militants killed some 1,200 Israelis and took more than 250 hostages, also inflicted hundreds of military casualties in the first hours. In the subsequent ground operations in Gaza, the IDF faced an urban warfare environment with high rates of penetrating trauma, blast injuries, and prolonged evacuation times. Early in the war, the IDF’s medical corps recognized that traditional casualty evacuation chains — which often required multiple handoffs and centralized triage — were too slow.
In response, the IDF implemented a series of reforms. Tourniquets and hemostatic gauze were distributed to every soldier, and all troops received basic “buddy aid” training. Medics were embedded at the platoon level rather than at the company level, cutting the time from injury to first treatment. Helicopter evacuation, previously reserved for the most severe cases, was authorized for a wider range of wounds, and field hospitals were pushed closer to the front lines. The military also adopted a “damage control resuscitation” protocol that prioritizes rapid transfusion of whole blood and plasma over large volumes of crystalloid fluids — a shift that has been shown to reduce coagulopathy and death.
According to data released by the IDF Medical Corps in mid-2024, the case fatality rate for wounded soldiers — the percentage of those who die after reaching medical care — dropped to levels well below historical averages for comparable conflicts. While exact figures remain classified, military medical officials have acknowledged that the rate is now among the lowest ever recorded for a major ground campaign. The improvement is especially notable for injuries that would have been fatal in previous wars, such as bilateral amputations and severe pelvic trauma.
**Analise**
The implications extend far beyond Israel. The United States has been the world’s largest investor in combat casualty care for decades, but the nature of modern warfare — with peer threats, long-range fires, and contested airspace — means that American troops may face similar challenges to those encountered by the IDF in Gaza: delayed evacuation, high-velocity fragmentation wounds, and limited access to surgical teams. The Pentagon’s Joint Trauma System has already begun a formal review of Israeli protocols, and several U.S. military medical units have conducted exchanges with their Israeli counterparts.
In February 2025, the U.S. Army’s Medical Research and Development Command hosted a delegation from the IDF Medical Corps to discuss prehospital care innovations. The focus areas included the use of whole blood in the field — a practice the U.S. military has been expanding but still faces logistical hurdles — and the integration of artificial intelligence tools for triage. The U.S. Marine Corps, which is preparing for potential amphibious operations in the Indo-Pacific, has also expressed interest in the IDF’s lightweight, portable blood storage systems.
Critics, however, caution that the Israeli experience may not be fully transferable. The IDF operates in a small theater with relatively short evacuation distances, and its forces benefit from a highly motivated, well-trained conscript population. The U.S. military, by contrast, must plan for global operations where evacuation times can stretch to hours, not minutes. Moreover, the ethical and legal frameworks for battlefield medicine differ between the two countries, particularly regarding the treatment of enemy combatants.
Nevertheless, the trend is clear: the IDF’s combat medicine reforms have saved lives at a scale that demands attention. The U.S. military’s interest is not merely academic. As the Pentagon prepares for potential high-intensity conflicts against China or Russia, the ability to keep wounded soldiers alive long enough for definitive care could be a decisive factor in sustaining combat power. The Israeli model offers a template — one that is already being adapted, tested, and debated inside the U.S. defense establishment.
**Fontes**
- IDF Medical Corps official statements and briefings (2024–2025). - U.S. Army Medical Research and Development Command press releases and congressional testimony. - Reports from the Israel Defense Forces’ casualty data published by the Israeli Ministry of Defense. - Academic papers in the Journal of Trauma and Acute Care Surgery on damage control resuscitation in the Gaza conflict. - Public remarks by U.S. military medical leaders at the Military Health System Research Symposium. - News articles from The Jerusalem Post, Haaretz, and Defense One covering the IDF medical reforms and U.S. interest.